Central pontine myelinolysis secondary to hypokalaemic nephrogenic diabetes insipidus

Annals of Clinical Biochemistry

Volumn 47, Issue 1, 2010, Pages 86-89

  Davenport, C ^a   Liew, A ^a   Vic Lau, P ^a   Smith, D ^a   Thompson, C J ^a   Kearns, G ^a   Agha, Amar ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM; CORTICOTROPIN; CREATININE; DESMOPRESSIN; GLUCOSE; ISOTONIC SOLUTION; MINERALOCORTICOID; POTASSIUM; SODIUM; SODIUM CHLORIDE; VITAMIN B COMPLEX;

ADULT; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; APPARENT MINERALOCORTICOID EXCESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; CALCIUM BLOOD LEVEL; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COMATOSE PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEMYELINATION; DISEASE SEVERITY; FLUID THERAPY; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERCAPNIA; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTONIC POLYURIA; HYPOTONIC POYLURIA; HYPOXEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRAVENOUS ADMINISTRATION; LABORATORY TEST; LUNG SEPSIS; MALE; NEPHROGENIC DIABETES INSIPIDUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PNEUMONIA; POLYURIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; RESPIRATORY FAILURE; SEPSIS; SODIUM BLOOD LEVEL; TREATMENT RESPONSE;

ALCOHOLISM; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; HYPOKALEMIA; MALE; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE;

EID: 75149141865     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009094     Document Type: Article

References (21)

1. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004;75(Suppl. 3):iii22-8
2. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002;47:3-10
3. Huq S, Wong M, Chan H, Crimmins D. Osmotic demyelination syndromes: central and extrapontine myelinolysis. J Clin Neurosci 2007;14:684-8 (Epub Apr 25 2007)
4. O'Malley G, Moran C, Draman MS, et al. Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state. Ann Clin Biochem 2008;45(part 4):440-3
5. Heng AE, Vacher P, Aublet-Cuvelier B, et al. Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia. Clin Nephrol 2007;67:345-51
6. Chang L, Harrington DW, Milkotic A, Swerdloff RS, Wang C. Unusual occurrence of extrapontine myelinolysis associated with acute severe hypernatraemia caused by central diabetes insipidus. Clin Endocrinol (Oxf) 2005;63:233-5
7. Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 2005;45:626-37
8. Oksche A, Rosenthal W. The molecular basis of nephrogenic diabetes insipidus. J Mol Med 1998;76:326-37
9. Smith DM, McKenna K, Thompson CJ. Hyponatraemia. Clin Endocrinol (Oxf) 2000;52:667-78
10. Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatraemia. N Engl J Med 1986;314:1535- 42
11. Cluitmans FH, Meinders AE. Management of severe hyponatremia: rapid or slow correction? Am J Med 1990;88:161-6
12. Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatraemia. Kidney Int 1991;39:1274-82
13. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol 2001;8:103-9
14. Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then. . .and now. J Neuropathol Exp Neurol 2006;65:1-11
15. Adams R, Victor M, Mancall E. Central pontine myelinolysis. A hitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol 1959;81:154-72
16. Shintani M, Yamashita M, Nakano A, et al. Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia. Diabetes Res Clin Pract 2005;68:75-80
17. Murase T, Sugimura Y, Takefuji S, Oiso Y, Murata Y. Mechanisms and therapy of osmotic demyelination. Am J Med 2006;119(Suppl. 1):S69-73
18. Baker EA, Tian Y, Adler S, Verbalis JG. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia. Exp Neurol 2000;165:221-30
19. Sugimura Y, Murase T, Takefuji S, et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 2005;192:178-83
20. Escribano-Gascón AB, Casanova-Peño LI, Bartolomé- Puras M, Porta-Etessam J. Efficacy of intravenous immunoglobulins in central pontine myelinolysis. Neurologia 2008;23:392-4
21. Deleu D, Salim K, Mesraoua B, El Siddig A, Al Hail H, Hanssens Y. 'Man-in-the-barrel' syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin. J Neurol Sci 2005;237:103-6